Medical Developments Valuation
| MVP Stock | 0.42 0.01 2.33% |
Medical Developments is overvalued. Medical Developments secures a last-minute Real Value of USD0.37 per share. The latest price of the firm is USD0.42. Our model forecasts the value of Medical Developments from analyzing the firm fundamentals such as Current Valuation of 39.3 M, return on equity of -0.65, and Profit Margin of (1.24) % as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.0223 | Enterprise Value 39.3 M | Enterprise Value Ebitda 278.771 | Price Sales 1.4274 | Forward PE 166.6667 |
Overvalued
Today
Please note that Medical Developments' price fluctuation is abnormally volatile at this time. Calculation of the real value of Medical Developments is based on 3 months time horizon. Increasing Medical Developments' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Medical Developments' intrinsic value may or may not be the same as its current market price of 0.42, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.42 | Real 0.37 | Hype 0.42 |
The intrinsic value of Medical Developments' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medical Developments' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medical Developments International helps investors to forecast how Medical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medical Developments more accurately as focusing exclusively on Medical Developments' fundamentals will not take into account other important factors: Medical Developments Cash |
|
Medical Developments Total Value Analysis
Medical Developments International is now projected to have takeover price of 39.3 M with market capitalization of 47.32 M, debt of 2.29 M, and cash on hands of 24.66 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medical Developments fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
39.3 M | 47.32 M | 2.29 M | 24.66 M |
Medical Developments Investor Information
About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.02. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medical Developments recorded a loss per share of 0.46. The entity last dividend was issued on the 5th of March 2020. Based on the key indicators related to Medical Developments' liquidity, profitability, solvency, and operating efficiency, Medical Developments International is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Medical Developments Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medical Developments has an asset utilization ratio of 56.03 percent. This implies that the Company is making USD0.56 for each dollar of assets. An increasing asset utilization means that Medical Developments International is more efficient with each dollar of assets it utilizes for everyday operations.Medical Developments Ownership Allocation
Medical Developments maintains a total of 112.66 Million outstanding shares. Medical Developments International secures significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Medical Developments stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medical Developments Profitability Analysis
The company reported the revenue of 33.15 M. Net Loss for the year was (40.99 M) with profit before overhead, payroll, taxes, and interest of 22.21 M.About Medical Developments Valuation
The stock valuation mechanism determines Medical Developments' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Medical Developments based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medical Developments. We calculate exposure to Medical Developments's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medical Developments's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 24.4 M | 25.6 M |
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.